Vorweg M, Monaca E, Doehn M, Wappler F
University of Witten/Herdecke, Department of Anesthesiology, Hospital Cologne-Merheim, Köln, Germany.
Eur J Anaesthesiol. 2006 Jan;23(1):50-3. doi: 10.1017/S0265021505001766.
The reasons for coagulopathy may be multiple and the identification of the underlying cause is often difficult. Recently, we identified two patients showing characteristics of heparin overdose during surgery. We hypothesised that filling a Shaldon dialysis catheter with heparin prior to closure, so-called heparin lock, might have triggered this coagulation disorder. Therefore, the aim of this in vitro study was to show whether this procedure can lead to an iatrogenic administration of heparin.
A Shaldon catheter (GamCath; Joka Kathetertechnik, Hechingen, Germany) was hung up in a container filled with NaCl solution 0.9% 5 mL and a heparin lock was simulated. Instead of using heparin solution we injected 1 mL of a KCl solution (1 mol L(-1)) into the Shaldon catheter, because the measurement of the potassium concentration is faster and more reliable than that of heparin. Ten measurements were taken after fast (0.5 s) and slow (3 s) injection speeds.
Although the catheter volume is specified as 1.07 mL, an amount up to 0.51 mL KCl solution on average was detectable in the solution after locking the catheter with 1 mL KCl solution.
Following a heparin lock a considerable amount of the injected solution is accidentally administered to the patient. Only 49.1% of the injected volume may remain in the Shaldon catheter. This could lead to an increased risk of coagulopathy.
凝血病的病因可能多种多样,往往难以确定根本原因。最近,我们发现两名患者在手术过程中表现出肝素过量的特征。我们推测,在关闭导管前用肝素填充Shaldon透析导管(即所谓的肝素封管)可能引发了这种凝血障碍。因此,本体外研究的目的是表明该操作是否会导致医源性肝素给药。
将一根Shaldon导管(GamCath;德国黑兴根的Joka Kathetertechnik公司生产)悬挂在装有5 mL 0.9%氯化钠溶液的容器中,模拟肝素封管。我们向Shaldon导管中注入1 mL氯化钾溶液(1 mol/L),而不是使用肝素溶液,因为钾浓度的测量比肝素测量更快且更可靠。在快速(0.5秒)和慢速(3秒)注射速度后进行了十次测量。
尽管导管容积规定为1.07 mL,但在用1 mL氯化钾溶液封管后,平均有多达0.51 mL的氯化钾溶液可在溶液中检测到。
肝素封管后,相当一部分注入的溶液会意外注入患者体内。注入的液体中只有49.1%可能留在Shaldon导管中。这可能会增加凝血病的风险。